UPDATED May 21, 2025
Discover large cap Norwegian Pharmaceuticals & Biotech companies that are on the OSEAX. These Pharmaceuticals & Biotech Companies are organised by Market Cap.
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
PHO | NOK 49.55 | -1.1% | -14.4% | NOK 1.3b | NOK 82.50 | PE616.6x | E89.1% | 0% | ||
VISTN | NOK 25.00 | 0.8% | 13.6% | NOK 1.1b | n/a | PE14.4x | n/a | 5.0% | ||
HBC | NOK 2.29 | -1.7% | 7.5% | NOK 941.4m | n/a | PS3.4x | n/a | n/a | ||
NYKD | NOK 2.72 | -2.2% | -81.2% | NOK 889.5m | NOK 6.75 | PS9.5x | E12.7% | 35.8% | ||
AZT | NOK 16.80 | -1.5% | -33.3% | NOK 858.0m | NOK 17.00 | PE391.4x | E75.5% | n/a | ||
TRMED | NOK 2.50 | 1.2% | 141.8% | NOK 784.4m | n/a | PB2.3x | n/a | n/a | ||
LYTIX | NOK 8.40 | 33.3% | 55.6% | NOK 573.4m | NOK 13.00 | PS943.1x | S39.7% | n/a | ||
NORD | NOK 80.00 | -0.1% | 95.1% | NOK 397.7m | n/a | PE3.2x | n/a | 0% | ||
NAVA | NOK 21.50 | 1.9% | -39.1% | NOK 379.7m | NOK 34.00 | PB1.8x | E90.4% | n/a | ||
ZLNA | NOK 13.50 | -5.2% | n/a | NOK 273.1m | n/a | PS5152.2x | n/a | n/a | ||
SOFTX | NOK 0.087 | -21.6% | -9.9% | NOK 194.9m | n/a | PS24.6x | n/a | n/a | ||
EXTX | NOK 2.64 | -14.8% | -62.8% | NOK 167.0m | n/a | PB1.4x | n/a | n/a | ||
ONCIN | NOK 1.60 | -6.1% | n/a | NOK 156.4m | NOK 2.70 | PS19.3x | E6.5% | n/a | ||
ABS | NOK 3.22 | 22.9% | -67.5% | NOK 86.5m | n/a | PS1.9x | n/a | n/a | ||
BGBIO | NOK 2.00 | 15.6% | -84.2% | NOK 78.2m | NOK 1.90 | PS92.2x | E12.9% | n/a | ||
PCIB | NOK 1.69 | -3.2% | 12.3% | NOK 62.9m | n/a | PS9.3x | n/a | n/a | ||
CRNA | NOK 0.61 | -8.3% | -76.2% | NOK 55.4m | NOK 1.00 | PE1x | n/a | n/a |